Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.27 - $8.76 $327,000 - $876,000
-100,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$7.56 - $14.3 $453,600 - $858,000
60,000 Added 150.0%
100,000 $819,000
Q4 2021

Feb 14, 2022

BUY
$12.24 - $21.25 $489,600 - $850,000
40,000 New
40,000 $571,000
Q3 2021

Nov 15, 2021

SELL
$16.69 - $26.05 $500,700 - $781,500
-30,000 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$18.15 - $27.75 $544,500 - $832,500
30,000 New
30,000 $759,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $265M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Cinctive Capital Management LP Portfolio

Follow Cinctive Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.